Search for: "OTC" Results 41 - 60 of 1,982
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Oct 2009, 1:22 pm
The House Financial Services Committee today approved legislation that would, for the first time ever, require the comprehensive regulation of the over-the-counter (OTC) derivatives marketplace. [read post]
29 Nov 2023, 9:40 am by Simon Lovegrove (UK)
The provisional agreement on the reform of the Markets in Financial Instruments Regulation includes reforms to the scope of pre- and post-trade transparency reporting for OTC derivatives, including by specifying the classes of OTC derivatives subject to pre- and post-trade transparency. [read post]
19 Oct 2022, 8:54 am by Hannah Meakin (UK)
On 18 October 2022, the European Commission published a Commission Delegated Regulation amending the regulatory technical standards laid down in Delegated Regulation (EU) 149/2013 as regards the value of the clearing threshold for positions held in over-the-counter (OTC) commodity derivatives contracts and other OTC derivative contracts. [read post]
26 Oct 2009, 2:17 pm
Following the House Financial Services Committee's approval of its version of proposed legislation to reform regulation of the OTC derivatives market on October 16, 2009, the House Agriculture Committee unanimously approved its own version of the bill on October 21, 2009. [read post]
4 May 2015, 7:39 am by Robert Kraft
CBS News reports the FDA has issued a warning that some of the common OTC medicines could make people “too drowsy” and affect their ability to drive safely. [read post]
4 Jul 2017, 4:43 am by Hannah Meakin and Mark Chalmers
This report provides a comprehensive review of the OTC derivatives market reforms and their effects; OTC Derivatives Market Reforms: Twelfth Progress Report on Implementation. [read post]
22 Dec 2020, 9:00 am by Staff
Healthcare makers, distributors, and sellers must comply with FDA rules and warning letters for their cannabis, hemp, and THC products including foods, OTC drugs, cosmetics, and dietary supplements The post What Happens If You Make Cosmetic, OTC Drug, or Dietary Supplement with Hemp, Cannabis, or THC – Part Two appeared first on Cohen Healthcare Law Group | Healthcare Lawyers | FDA & FTC Law. [read post]
20 Sep 2021, 10:00 pm
The Financial Industry Regulatory Authority (FINRA) published a regulatory notice (RN 21-32) on September 14, 2021 requesting comment on its policy relating to the assignment of OTC symbols to unlisted equity securities. [read post]
20 Sep 2021, 10:00 pm
The Financial Industry Regulatory Authority (FINRA) published a regulatory notice (RN 21-32) on September 14, 2021 requesting comment on its policy relating to the assignment of OTC symbols to unlisted equity securities. [read post]
20 Sep 2021, 10:00 pm
The Financial Industry Regulatory Authority (FINRA) published a regulatory notice (RN 21-32) on September 14, 2021 requesting comment on its policy relating to the assignment of OTC symbols to unlisted equity securities. [read post]
20 Sep 2021, 10:00 pm
The Financial Industry Regulatory Authority (FINRA) published a regulatory notice (RN 21-32) on September 14, 2021 requesting comment on its policy relating to the assignment of OTC symbols to unlisted equity securities. [read post]
20 Sep 2021, 10:00 pm
The Financial Industry Regulatory Authority (FINRA) published a regulatory notice (RN 21-32) on September 14, 2021 requesting comment on its policy relating to the assignment of OTC symbols to unlisted equity securities. [read post]
20 Sep 2021, 10:00 pm
The Financial Industry Regulatory Authority (FINRA) published a regulatory notice (RN 21-32) on September 14, 2021 requesting comment on its policy relating to the assignment of OTC symbols to unlisted equity securities. [read post]
While MiFIR introduced trade transparency requirements for OTC-derivatives, including single name CDS, the actual transparency provided on trading activity in these instruments remains limited. [read post]
20 Jan 2022, 5:58 pm by The Perazzo Law Firm, P.A.
Miami Personal Injury Lawyer shares information on quick COVID-19 tests and OTC tests. [read post]
13 Feb 2022, 10:00 pm
The US Food and Drug Administration (FDA) on February 1 issued a draft guidance, “Formal Meetings Between FDA and Sponsors or Requestors of OTC Monograph Drugs” (Meeting Guidance), that specifies the procedures and principles for meetings between FDA and meeting requestors. [read post]
13 Feb 2022, 10:00 pm
The US Food and Drug Administration (FDA) on February 1 issued a draft guidance, “Formal Meetings Between FDA and Sponsors or Requestors of OTC Monograph Drugs” (Meeting Guidance), that specifies the procedures and principles for meetings between FDA and meeting requestors. [read post]
13 Feb 2022, 10:00 pm
The US Food and Drug Administration (FDA) on February 1 issued a draft guidance, “Formal Meetings Between FDA and Sponsors or Requestors of OTC Monograph Drugs” (Meeting Guidance), that specifies the procedures and principles for meetings between FDA and meeting requestors. [read post]